Steris (STE) Total Debt Growth (3y) (2021 - 2026)
Powered by 
Analysis
Steris (STE) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | -10.56% |
| 10 | Zimmer Biomet Holdings | 17.80 Bn | 17.39 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.56% |
| Mar 31, 2026 | -13.23% |
| Dec 31, 2025 | -15.28% |
| Sep 30, 2025 | -15.78% |
| Jun 30, 2025 | -15.45% |
| Mar 31, 2025 | -12.45% |
| Dec 31, 2024 | -12.62% |
| Sep 30, 2024 | -12.57% |
| Jun 30, 2024 | -11.29% |
| Mar 31, 2024 | 25.88% |
| Dec 31, 2023 | 25.52% |
| Sep 30, 2023 | 50.92% |
| Jun 30, 2023 | 39.85% |
| Mar 31, 2023 | 39.73% |
| Dec 31, 2022 | 40.03% |
| Sep 30, 2022 | 38.82% |
| Jun 30, 2022 | 37.54% |
| Mar 31, 2022 | 39.78% |
| Mar 31, 2021 | 7.84% |